Army Drug Development Program. Phase I. Clinical Testing.
Annual rept. Feb 79-Jan 80,
BIO-MED INC COLLEGE PARK MD
Pagination or Media Count:
In this reporting period, the drug blood levels from the 52 week study of safety and tolerance of Mefloquine WR 142,490, Experiment 1 became available. It then became desirable to correlate these data with the myriad observations and measurements made of 46 subjects over the course of one year. In six months of sustained effort under the guidance and supervision of the Division of Experimental Therapeutics of WRAIR, BIO-MED, Inc. wrote programs for the orderly storage and collation of the laboratory data 24,288 Discreet laboratory observations spread over 52 weeks to be accounted for, and entered the formatted data into the Tektronic 4051 table top computer system. The data are now stored in an accessible format on floppy discs, compatible with the WRAIR and BIO-MED, Inc. system.